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Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease, characterized by distorted lung architecture and loss
of respiratory function. Alveolar epithelial cell injury and hyperplasia, enhanced extracellular matrix deposition, and
(myo)fibroblast activation are features of IPF. Wnt/b-catenin signaling has been shown to determine epithelial cell fate
during development. As aberrant reactivation of developmental signaling pathways has been suggested to contribute to
IPF pathogenesis, we hypothesized that Wnt/b-catenin signaling is activated in epithelial cells in IPF. Thus, we quantified
and localized the expression and activity of the Wnt/b-catenin pathway in IPF.
Methodology/Principal Findings: The expression of Wnt1, 3a, 7b, and 10b, the Wnt receptors Fzd1-4, Lrp5-6, as well as the
intracellular signal transducers Gsk-3b, b-catenin, Tcf1, 3, 4, and Lef1 was analyzed in IPF and transplant donor lungs by
quantitative real-time (q)RT-PCR. Wnt1, 7b and 10b, Fzd2 and 3, b-catenin, and Lef1 expression was significantly increased in
IPF. Immunohistochemical analysis localized Wnt1, Wnt3a, b-catenin, and Gsk-3b expression largely to alveolar and
bronchial epithelium. This was confirmed by qRT-PCR of primary alveolar epithelial type II (ATII) cells, demonstrating a
significant increase of Wnt signaling in ATII cells derived from IPF patients. In addition, Western blot analysis of phospho-
Gsk-3b, phospho-Lrp6, and b-catenin, and qRT-PCR of the Wnt target genes cyclin D1, Mmp 7, or Fibronectin 1
demonstrated increased functional Wnt/b-catenin signaling in IPF compared with controls. Functional in vitro studies
further revealed that Wnt ligands induced lung epithelial cell proliferation and (myo)fibroblast activation and collagen
synthesis.
Conclusions/Significance: Our study demonstrates that the Wnt/b-catenin pathway is expressed and operative in adult
lung epithelium. Increased Wnt/b-catenin signaling may be involved in epithelial cell injury and hyperplasia, as well as
impaired epithelial-mesenchymal cross-talk in IPF. Thus, modification of Wnt signaling may represent a therapeutic option
in IPF.
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Introduction
Pulmonary fibrosis can result from a variety of causes, including
lung injury, environmental particle and toxin inhalation, chemo-
therapy, systemic autoimmune diseases, or as an idiopathic entity
in form of idiopathic interstitial pneumonias (IIP) [1–4]. Idiopathic
pulmonary fibrosis (IPF), the most common form of IIP, represents
a progressive and lethal disorder with unresolved pathogenesis and
unresponsiveness to currently available therapies [5]. Distortion of
the normal lung architecture in IPF is evident by temporo-spatially
heterogeneous histology, including areas of normal parenchyma,
mild interstitial inflammation due to mononuclear infiltrates,
septal fibrosis with subepithelial fibroblast foci, and honeycombing
[6,7].
Fibroblast foci represent the hallmark lesions of IPF, as they
constitute aggregates of activated myofibroblasts, which promote
excessive ECM deposition [7]. The occurrence of fibroblast foci
represents an important prognostic factor, since their numbers
have been correlated with survival in IPF [8]. Fibroblast foci occur
in subepithelial layers, close to areas of alveolar epithelial cell
injury and repair, suggesting that impaired epithelial-mesenchy-
mal crosstalk contributes to the pathobiology of IPF [8,9]. Indeed,
it is well accepted that repetitive injury and subsequent repair of
alveolar epithelial type II (ATII) cells, in the presence or absence of
local inflammation, represent a key pathogenic mechanism in IPF,
which leads to aberrant growth factor activation and perpetuation
of fibrotic transformation [10]. Although several soluble media-
tors, such as transforming growth factor (TGF)-b1 or interleukin
(IL)-1b, have been assigned a clear pathogenic role in IPF and
experimental models thereof (9, 10), therapeutic options neutral-
izing their activity have not been successful in clinical use as of yet.
The Wnt family constitutes a large family of highly conserved
secreted growth factors essential to organ development, a process
often recapitulated in organ failure. The best characterized Wnt
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signaling pathway [11–13]. Here, in the absence of active Wnt
ligands, b-catenin is constitutively phosphorylated by its interac-
tion with axin, adenomatosis polyposis coli (APC), and glycogen
synthase kinase (Gsk)-3b, and subsequently degraded. In the
presence of Wnt ligands, two distinct membrane receptors, the
frizzled (Fzd) or the low density lipoprotein receptor-related
proteins (Lrp) 5 and 6, are activated upon ligand binding. In detail,
Wnt stimulation leads to phosphorylation of Lrp6 by Gsk-3b and
casein kinase c in its cytoplasmic region, which leads to the
recruitment of axin. Subsequently, b-catenin phosphorylation is
attenuated, its degradation inhibited, and accumulated b-catenin
undergoes nuclear translocation, where it regulates target gene
expression through interaction with members of the T-cell-specific
transcription factor/lymphoid enhancer-binding factor (Tcf/Lef)
family [11,12].
Importantly, increased nuclear b-catenin staining was recently
reported in IPF tissue sections [14], indicative of increased Wnt
signaling. In addition, unbiased microarray screens have also
revealed an increased expression of Wnt target genes, such as
matrix metalloproteinase (Mmp) 7, or secreted frizzled-related
protein (Sfrp) 2 in IPF [15–17]. We therefore hypothesized that
canonical Wnt signaling is aberrantly activated in IPF, recapitu-
lating developmentally active programs in this chronic disease. To
this end, we achieved our aim to elucidate the expression,
localization, and activity of the Wnt/b-catenin pathway in IPF.
Results
Initially, we sought to quantify the mRNA expression of
canonical Wnt/b-catenin signaling components in lung tissue
samples of transplant donors and IPF patients using quantitative
real-time (q)RT-PCR. As depicted in Figure 1a, canonical Wnt
ligands were variably expressed in the human lung. Wnt1, 2, 3a,
and 7b were expressed at similar levels in normal lung tissue, while
Wnt10b was only little expressed. In IPF lung specimens, Wnt1,
7b, and 10b mRNA levels were markedly upregulated (log-fold
change of 1.1960.43, 1.0560.43, and 1.5860.59, respectively),
whereas Wnt3a was significantly downregulated (log-fold change
21.9360.65) (Figure 1a).
Next, we analyzed the expression of common Wnt receptors
and co-receptors. As shown in Figure 1b, the most abundant
receptors in the human lung were Fzd1 and 4, and the co-
receptors Lrp5 and 6, but their expression was similar in control
and IPF lungs. Interestingly, Fzd2 and 3 were expressed at low
levels in control as well as IPF lungs, but significantly increased in
IPF (log-fold change 1.0460.24 and 1.4160.31, respectively)
(Figure 1b).
Figure 1. The mRNA expression profile of canonical Wnt signaling components in IPF. The mRNA levels of the Wnt ligands Wnt1, 2, 3a, 7b,
and 10b (a), the receptors frizzled (Fzd) 1–4, low density lipoprotein-related protein (Lrp) 5 and 6 (b), and the intracellular signal transducers glycogen
synthase kinase (Gsk)-3b, b-catenin, T-cell-specific transcription facor (Tcf) 3, Tcf 4, lymphoid enhancer-binding factor (Lef) 1 (c) were assessed in
donor and IPF lung specimen by quantitative real-time PCR (qRT-PCR). Results are derived from 12 donors and 12 IPF patients and presented as
mean6s.e.m., * p,0.05.
doi:10.1371/journal.pone.0002142.g001
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catenin were both expressed in normal and fibrotic lung tissue,
with a significantly increased expression of b-catenin in IPF (log-
fold change 0.9860.28) (Figure 1c). With the exception of Tcf1, all
members of the Tcf/Lef family of transcription factors were
expressed in normal and fibrotic lung tissue. Lef1 was significantly
upregulated in IPF (log-fold change 0.8560.34) (Figure 1c).
We went on to localize cell types capable of Wnt ligand
secretion, as assessed by immunohistochemistry of Wnt1 and 3a
ligands, and cell types capable of Wnt signaling, as assessed by
immunohistochemistry of b-catenin and Gsk-3b, in donor and IPF
lung tissue (Figure 2, 3, 4, 5). Wnt1 was mainly expressed in
bronchial and alveolar epithelium, with strong staining of alveolar
epithelial type II (ATII) cells (Figure 2). Additionally, Wnt1 was
expressed in vascular smooth muscle cells (Figure 2a, upper panel).
In IPF (Figure 2b), Wnt1 staining was observed in hyperplastic
ATII cells and bronchial epithelial cells. An apical staining pattern
of Wnt1 in bronchial epithelial cells was observed in IPF,
suggesting increased secretion of Wnt1. Interestingly, Wnt1 was
also expressed by endothelial cells in IPF tissues (Figure 2b, lower
panel, arrowhead). Wnt3a protein expression was mainly detected
in ATII cells (Figure 3a, b, lower panels) and selected ciliated
bronchial epithelial cells (Figure 3a, b, upper panels) in donor as
well as IPF lung tissue.
We then analyzed protein expression pattern of b-catenin and
Gsk-3b (Figure 4 and 5, respectively). Strong membranous and
cytoplasmic b-catenin expression was observed in bronchial
epithelial and ATII cells, as well as endothelial cells in donor
lung tissue (Figure 4a, arrowhead). Importantly, in IPF, b-catenin
expression was less membranous and enhanced in the cytoplasm,
with clear nuclear staining observed in single cells (Figure 4b,
arrow). Strong b-catenin expression was noticed in hyperplastic
ATII cells, in particular in areas of bronchiolization (Figure 4b), as
assessed by immunohistochemistry. Gsk-3b showed a very similar
expression pattern to b-catenin, with predominant staining in
bronchial epithelial and ATII cells, as well as endothelial cells in
donor lung tissues (Figure 5a, arrowhead). In IPF lungs, intense
staining of basal bronchial epithelial and hyperplastic ATII cells
was observed (Figure 5b). Taken together, the Wnt/b-catenin
system was largely expressed in the bronchial and alveolar
epithelium in normal and IPF tissue.
To further corroborate these results, we quantified cell-specific
gene expression of Wnt/b-catenin signaling components in
primary human ATII cells and fibroblasts derived from IPF
patients or transplant donors, using qRT-PCR (Figure 6). As
depicted in Figure 6a, we observed increased mRNA expression of
Wnt7b and 10b in ATII cells from IPF patients. Wnt3a was
downregulated in IPF ATII cells, while Wnt1 levels remained
Figure 2. Expression and localization of Wnt1 in lung tissues of donor and IPF patients. Immunohistochemical staining was performed on
tissue sections of donor (a) or IPF lungs (b). Representative pictures with focus on the bronchial (upper panel) or alveolar epithelium (lower panel) are
given. Stainings are representative of two independent experiments using at least three different donor or IPF lung tissues (magnification as
indicated). Arrowhead indicates positive endothelial cells.
doi:10.1371/journal.pone.0002142.g002
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mRNA levels of the receptor Fzd3 and the intracellular signaling
molecules Gsk-3b, b-catenin, and Lef1 in IPF ATII cells (Figure 6b
and 6c, respectively). Interestingly, we routinely observed higher
expression levels of these components in primary ATII cells
compared with fibroblasts (data not shown), thereby confirming
our localization analysis. In sum, these data revealed the
expression of all required Wnt components in the lung, and
significant upregulation thereof in IPF, mainly in the bronchial
and alveolar epithelium.
To accurately assess, whether the Wnt/b-catenin signaling
pathway was activated in IPF, we performed Western blot analysis
of phospho-Gsk-3b, phospho-Lrp6, and b-catenin. As presented in
Figure 7a, we observed an increased phosphorylation of both, Gsk-
3b and Lrp6, in IPF. This is consistent with increased expression
of total b-catenin (Figure 7a), and indicative of activated Wnt/b-
catenin signaling. Next, we analyzed the expression of the well-
characterized Wnt target genes fibronectin (Fn) 1, matrix
metalloproteinase (Mmp) 7, and cyclin D1 in IPF lungs. As
depicted in Figure 7b, all of these Wnt target genes were
upregulated in IPF lung samples, as compared with transplant
donor samples.
We then sought to investigate biological effects elicited by Wnt
ligands on key cell types involved in IPF pathogenesis. To this end,
we assessed proliferation, as well as (myo)fibroblast activation and
collagen deposition in A549 lung epithelial cells und NIH-3T3
fibroblasts, respectively. Using a Tcf/Lef-driven reporter gene
assay, we first demonstrated that Wnt3a elicited a potent
canonical Wnt/b-catenin response, while Wnt7a did not (fold
induction of 8.9661.59 and 0.8960.09 for Wnt3a and Wnt7a,
respectively; Figure 8a). Furthermore, Wnt3a stimulation led to a
strong increase of A549 cell proliferation (268610
3628610
3
versus 119610
3616610
3 for Wnt3a and control, respectively;
Figure 8b).
Wnt3a led to a significant induction of the Wnt target gene
cyclin D1 and the myofibroblast activation markers smooth muscle
actin (Acta2) and fibroblast-specific protein (Fsp) 1, as assessed by
qRT-PCR of Wnt3a- or vehicle-treated fibroblasts (Figure 9a).
This coincided with increased collagen production, assessed by
Sircol assays, in response to Wnt3a, to levels similar to those due to
treatment with TGF-b1 (fold induction of 3.0760.3 and 2.660.2
for Wnt3a and TGF-b1, respectively; Figure 9b). This was
confirmed by immunofluorescence staining of type I collagen in
fibroblasts, demonstrating increased collagen staining in response
to Wnt3a (Figure 9c). In contrast, Wnt3a treatment did not affect
fibroblast proliferation (data not shown), suggesting that Wnt
ligands elicit profibrotic effects in a cell-specific manner on
resident lung cells.
Figure 3. Expression and localization of Wnt3a in lung tissues of donor and IPF patients. Immunohistochemical staining was performed
on tissue sections of donor (a) or IPF lungs (b). Representative pictures with focus on the bronchial (upper panel) or alveolar epithelium (lower panel)
are given. Stainings are representative of two independent experiments using at least three different donor or IPF lung tissues (magnification as
indicated).
doi:10.1371/journal.pone.0002142.g003
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IPF is the most common form of the idiopathic interstitial
pneumonias. IPF exhibits a poor prognosis and unresponsiveness
to currently available therapies, reflecting our limited understand-
ing of the basic mechanisms and mediators implicated in the
pathogenesis of this progressive and fatal disease [4,5]. Historical-
ly, inflammatory processes were thought to represent the main
trigger of IPF initiation and progression. This view has recently
been questioned, due to the ineffectiveness of anti-inflammatory
therapies in IPF [10]. Major key pathophysiological events in IPF
currently discussed include repetitive alveolar epithelial cell
injuries, in the presence or absence of local inflammation,
impaired epithelial-mesenchymal crosstalk, and subsequent fibro-
blast to myofibroblast activation [10,18–20]. These mechanisms
are mediated by aberrantly activated signaling molecules that
drive the fibrotic process, such as TGF-b, IGF, PDGF, or TNF-a
[9,20].
In this respect, the Wnt signaling system is of particular interest,
as it constitutes a developmentally active pathway, which is
reactivated in chronic diseases characterized by pathologic tissue
remodeling [11–13,21,22]. Unbiased microarray screens have
recently revealed the overexpression of Wnt target genes,
including Wnt-induced signaling pathway protein (Wisp) 1, matrix
metalloproteinase (Mmp) 7, or secreted frizzled-related protein
(Sfrp) 2, in IPF lungs [16,17,22]. Furthermore, a recent study
localized b-catenin staining to the nuclei of ATII cells and
interstitial fibroblasts in IPF lungs [14], suggestive of activated Wnt
signaling [23]. Thus, we hypothesized in our study that canonical
Wnt signaling is reactivated in IPF lungs, in particular in
hyperplastic ATII cells, thus contributing to disease development
and progression in IPF. While this has not yet been adressed in the
adult lung, canonical Wnt/b-catenin signaling is known to play an
essential role in lung development, as lung epithelial cell-specific
deletion of b-catenin prevents formation of the distal, but not the
proximal airways [24]. Furthermore, epithelial-cell specific
expression of constitutively active b-catenin leads to epithelial cell
dysplasia and abnormal epithelial differentiation in mice [25].
To this end, we performed a comprehensive analysis of
canonical Wnt signaling components at the mRNA and protein
level, assessing expression, localization, as well as activity of Wnt
ligands, receptors, and intracellular signaling molecules in IPF. We
demonstrate that all essential components were expressed in the
human lung, and particularly localized to the alveolar and
bronchial epithelium in normal, as well as IPF lungs, as
demonstrated by qRT-PCR and immunohistochemistry. Lung
homogenate, as well as cell-specific analysis of Wnt ligands and
Figure 4. Expression and localization of total b-catenin in lung tissues of donor and IPF patients. Immunohistochemical staining was
performed on tissue sections of donor (a) or IPF lungs (b). Representative pictures with focus on the bronchial (upper panel) or alveolar epithelium
(lower panel) are given. Stainings are representative of two independent experiments using at least three different donor or IPF lung tissues
(magnification as indicated). Arrow indicates nuclear staining of b-catenin. Arrowhead indicates positive endothelial cells.
doi:10.1371/journal.pone.0002142.g004
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(compare Figures 1 and 6), with the exception of Wnt1. While
Wnt1 was increased in IPF lung homogenates, it was not regulated
in IPF ATII cells, suggesting that other cell types, including
bronchial epithelial cells or endothelial cells (Figure 2), may serve
as the primary source for Wnt1 expression in IPF.
Similar to the Wnt ligands, Gsk-3b and b-catenin were highly
expressed in hyperplastic ATII cells and bronchiolar epithelial
cells at sites of bronchiolization in IPF. This suggests that Wnt
signaling, which is known to drive epithelial cell hyperplasia in
non-pulmonary epithelia [13], may regulate ATII cell hyperplasia
and increased bronchial epithelial cell proliferation in IPF.
Together with our observation that Wnt ligands are mainly
secreted by lung epithelial cells, this indicates that Wnt signaling in
the adult lung initiates from the epithelium and acts in an
autocrine and paracrine fashion on epithelial and mesenchymal
cells, respectively. While this has been underappreciated in the
normal and diseased adult lung, it represents a very well-
documented pathway active in the developing lung [23].
Our current understanding about the functional relevance of
Wnt signaling in lung epithelium is largely derived from transgenic
animal models. If deleted by homologous recombination in mice,
Wnt5a deficiency leads to overexpansion of distal airways and
inhibition of lung maturation, accompanied by enlarged inter-
saccular interstitial compartments [26]. Similarly, the loss of
Wnt7b causes perinatal death due to respiratory failure,
subsequent to impaired mesenchymal growth and vascular
development that is due to defective autocrine and paracrine
Wnt signaling by the airway epithelium [27]. Here, we also report
that Wnt ligands induce lung epithelial cell proliferation and
fibroblast activation and collagen synthesis (Figures 8, 9). These
observations further support the importance of properly regulated
Wnt signaling for normal epithelial-mesenchymal interactions, and
emphasize the impact of dysregulated Wnt signaling in diseases
characterized by an impairment thereof, such as IPF.
In this study, we used recombinant Wnt3a to assess the
functional effects of canonical Wnt signaling in epithelial cells and
fibroblasts. While we observed decreased expression of Wnt3a in
IPF homogenates and ATII cells (Figures 1 and 6), we proceeded
with Wnt3a for the following reasons: First, Wnt3a has been
repeatedly reported to potently stimulate b-catenin-dependent
Wnt signaling in vitro [28], and has been recognized as the
prototypic Wnt ligand for in vitro stimulations [11]. Second,
Wnt3a is one of the few Wnt ligands that is available in active and
recombinant form. Other Wnt ligands used in in vitro studies, such
as Wnt1, are commonly either overexpressed by viral transduc-
tion, or supplied in the form of conditioned media harvested from
Wnt1 overexpressing cell lines [29,30]. As we sought to define
Figure 5. Expression and localization of total Gsk-3b in lung tissues of donor and IPF patients. Immunohistochemical staining was
performed on tissue sections of donor (a) or IPF lungs (b). Representative pictures with focus on the bronchial (upper panel) or alveolar epithelium
(lower panel) are given. Stainings are representative of two independent experiments using at least three different donor or IPF lung tissues
(magnification as indicated). Arrowhead indicates positive endothelial cells.
doi:10.1371/journal.pone.0002142.g005
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were isolated from lung tissues of donor and IPF patients as described in Material and Methods. The mRNA levels of Wnt1, 3a, 7b, and 10b (a), the
receptors Fzd2 and 3, and Lrp5 and 6 (b), and Gsk-3b, b-catenin, and Lef1 (c) in ATII cells were assessed by qRT-PCR. Results are derived from 3
different cell isolations each and presented as mean6s.e.m., * p,0.05.
doi:10.1371/journal.pone.0002142.g006
Figure 7. Activity of the canonical Wnt signal pathway in lung homogenates of donor and IPF patients. (a) The expression of active Wnt
components in lung homogenates of donor and IPF patients was analyzed by immunoblotting of phosphorylated Gsk-3b and Lrp6, total b-catenin,
and the Wnt target gene Cyclin D1. Blotting of total Gsk-3b, Lrp6, and lamin A/C served as loading controls. Immunoblotting of smooth muscle actin
(ActA2) was used as a positive control for IPF specimen. (b) The mRNA levels of Fn 1, Mmp 7, and Cyclin D1 were assessed by qRT-PCR. Results are
derived from 6 donors and 6 IPF patients and presented as mean6s.e.m., * p,0.05.
doi:10.1371/journal.pone.0002142.g007
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therefore chose to proceed with Wnt3a stimulation.
One of the key questions arising from this study is whether
different Wnt isoforms, such as Wnt1 and Wnt3a, are able to
induce different effects, or whether they are merely expressed in a
distinct spatio-temporal fashion in the lung to elicit different
phenotypes, if deleted in mice. In general, a specific biological
effect induced by Wnt ligand exposure depends on the expression
of distinct Wnt receptors and signaling molecules, distinct ECM
molecules such as glypicans, but also on the presence of Wnt
inhibitors, such as Dickkopfs, secreted frizzled receptor proteins, or
Wnt inhibitory factor [31,32]. Second, different affinities of Wnt
ligands for distinct receptor subtypes have been shown to encode
signal specificity [32–34]. Third, crosstalk between Wnt/b-catenin
signaling with other pathways, such as the TGF-b pathway, may
induce tissue- and cell-type-specific effects of relevance to IPF. Of
interest, it has recently been demonstrated that the Wnt/b-catenin
signaling compounds axin and GSK-3 impact TGF-b signaling via
controling Smad3 protein stability [35].
We also demonstrated increased levels of b-catenin in IPF,
which were predominantly localized to bronchial epithelial and
hyperplastic ATII cells. In contrast to a previous investigation
presenting increased nuclear b-catenin staining in bronchial
epithelial and ATII cells, as well as interstitial fibroblasts [14],
we did not observe widespread nuclear staining of b-catenin using
immunohistochemistry in our study. This may be due to different
antibody or tissue preparations in these two studies, but moreover
suggests that Wnt activation in IPF is more subtle than previously
assumed. This may also indicate that only a minority of the
cellular b-catenin content in epithelial cells is responsible for Wnt
signaling, while the majority of b-catenin molecules is present
within the cytosol and at cell-cell contacts [36,37]. Therefore, to
generate a more comprehensive yet concise view of Wnt signaling
activity in IPF, we sought to combine expression and localization
analysis of Wnt signaling components, paired with phosphoryla-
tion analysis of Lrp6 and Gsk-3b, together with quantitative
expression analysis of Wnt target genes.
In sum, we report increased functional Wnt signaling in IPF,
documented by increased phosphorylation of Lrp6 and Gsk-3b,
which has recently been demonstrated to present as a most
sensitive indicator of Wnt activity in tissue sections [38,39]. We
also observed increased expression of the Wnt target genes Cyclin
D1, Mmp 7, and Fibronectin 1. In particular, Mmp 7 and
Fibronectin 1 have recently been assigned a causative role in
pulmonary fibrosis and shown to be expressed in interstitial
fibroblasts and ATII cells [40,41]. The Wnt signaling pathway
may therefore present as a novel pathogenic system re-activated
during chronic tissue remodeling observed in IPF [22]. As pointed
out in this study, Wnt ligands are secreted in a cell-specific fashion,
but act on a multitude of adjacent cell types, thereby modifying
Wnt ligand activity by cellular traps. Future in vitro and in vivo
studies will undoubtedly shed more light on the mechanistic
principles underlying Wnt activation in IPF, and whether
therapeutic modulation thereof will present as a suitable
therapeutic tool in this devastating disease.
Materials and Methods
Antibodies and reagents
The following antibodies were used in this study: Total b-
catenin (#9562), phospho-S9- and total Gsk-3b (#9336 and
#9315, respectively), phospho- and total Lrp6 (#2568 and
#2560, respectively; all from Cell Signaling Technology, Beverly,
MA), Wnt1 (ab15251, Abcam, Cambridge, UK), Wnt3a (38-2700,
Zymed Laboratories/Invitrogen, Carlsbad, CA), CyclinD1 (06-
137, Upstate, Temecula, CA), a-smooth muscle actin (SMA,
A2547, Sigma-Aldrich, Saint Louis, MO), collagen type 1
(T40777R, Biodesign, Saco, ME) and Lamin A/C (sc-20681,
Santa Cruz Biotechnology, Santa Cruz, CA). Dulbecco’s modified
Eagle’s medium (DMEM) and fetal calf serum (FCS) were
obtained from Invitrogen. Recombinant Wnt3a and Wnt7a was
purchased from R&D Systems.
Human tissues
Lung tissue biopsies were obtained from 15 IPF patients with
histological usual interstitial pneumonia (UIP) pattern (4 females,
11 males; mean age=5868 years; mean VC=48%67%; mean
TLC=50%65%; mean DLCO/VA=23%63%; O2=2–4 l/
min; PaO2=49–71 mmHg, PaCO2=33–65 mmHg) and 9 control
subjects (organ donors; 4 females, 5 males; mean age 42610
years). Individual patient characteristics are shown in Table 1.
Samples were immediately snap frozen or placed in 4% (w/v)
Figure 8. Proliferative effect induced by Wnt3a in alveolar epithelial cells. (a) A549 lung epithelial cell were transiently transfected with
FOPflash or TOPflash Wnt reporter constructs (FOP and TOP, respectively), and stimulated with Wnt3a or Wnt7a (at 100 ng/ml each), as indicated.
Luciferase expression is plotted as fold activation over unstimulated controls. Results are derived from six independent experiments and presenteda s
mean6s.e.m., * p,0.05. (b) Proliferation of A549 cells was assessed by cell counting 24 h after stimulation with Wnt3a (100 ng/ml). All experiments
were performed in quadruplicate, with each condition counted at least three times. Results are presented as mean6s.e.m., * p,0.05.
doi:10.1371/journal.pone.0002142.g008
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approved by the Ethics Committee of the Justus-Liebig-University
School of Medicine (AZ 31/93). Informed consent was obtained in
written form from each subject for the study protocol.
Cell culture
Human alveolar epithelial type II (ATII) cells were isolated, as
previously described [42]. The purity and viability of ATII cell
preparations was consistently .90% and .95%, respectively.
Primary human fibroblasts were generated by explant cultures as
previously described. Identification of fibroblasts was based on the
expression of vimentin, collagen, and aSMA [43]. The NIH-3T3
murine fibroblast cell line [German Collection of Microorganisms
and Cell Cultures (DSMZ, Braunschweig, Germany)] and the
human lung epithelial cell line A549 (ATCC #CCL-185) were
maintained in DMEM containing 10% FCS and cultured in a
humidified atmosphere of 5% CO2 at 37uC.
Reverse transcription and quantitative real-time PCR
Total RNA was extracted using Qiagen extraction kits
according to the manufacturer’s protocol, and cDNAs were
generated by reverse transcription using SuperScript
TM II
(Invitrogen) [43,44]. Quantitative (q)RT-PCR was performed
using fluorogenic SYBR Green and the Sequence Detection
System Fast 7500 (PE Applied Biosystems), as previously
described. Hprt1 and Pbgd, ubiquitously and equally expressed
genes free of pseudogenes, were used as a reference gene in all
human and mouse qRT-PCR reactions, respectively. PCR was
performed using the primers listed in Table 2, at a final
concentration of 200 nM. Relative transcript abundance of a
gene is expressed in DCt values (DCt=Ct
reference –C t
target).
Relative changes in transcript levels compared to controls are
DDCt values (DDCt=DCt
treated – DCt
control). All DDCt values
correspond approximately to the binary logarithm of the fold
change as mentioned in the text. When relative transcript
Figure 9. Myofibroblast activation and collagen deposition in response to Wnt3a. (a) The mRNA levels of the Wnt target gene Cyclin D1,
or the myofibroblast activation markers smooth muscle actin (Acta2) and fibroblast-specific protein (Fsp) 1 were analyzed by qRT-PCR. Results are
derived from 3 independent experiments and presented as mean6s.e.m., * p,0.05. (b) The total collagen content of NIH-3T3 fibroblasts stimulated
with Wnt3a (100 ng/ml) or TGF-b1 (2 ng/ml) for 24 h was quantified using the Sircol collagen assay. Results are derived from 5 independent
experiments and presented as mean6s.e.m., * p,0.05. (c) Fibroblast collagen expression and localisation after Wnt3a stimulation for 24 h was also
assessed by immunofluorescent detection of collagen type 1 (red). Nuclei were visualized by DAPI staining (blue). Control negative immunostainings
using iso-type matched IgG instead of a specific primary antibody are demontrated in the inlets of the left panels. Data are representative for at least
three independent experiments.
doi:10.1371/journal.pone.0002142.g009
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Immunohistochemistry
Human lungs were placed in 4% (w/v) paraformaldehyde after
explantation, and processed for paraffin embedding. Sections
(3 mm) were cut, mounted on slides, subjected to antigen retrieval,
and quenching of endogenous peroxidase activity using 3% (v/v)
H2O2 for 20 min. Immune complexes were visualized using
suitable peroxidase-coupled secondary antibodies, according to the
manufacturer’s protocol (Histostain Plus Kit; Zymed/Invitrogen)
[43,44].
Immunofluorescence
NIH-3T3 cells were plated on chamber slides, fixed with
acetone/methanol (1:1), and blocked for unspecific binding sites
with 3% (m/vol) BSA. Fixed cells were incubated with the
indicated primary antibodies for 60 min in PBS containing 0.1%
(m/vol) BSA. Indirect immunofluorescence was performed by
incubation with Alexa 555-conjugated secondary antibodies
(Molecular Probes, Eugene, Oregon). Nuclei were visualized by
4,6-diamidino-2-phenylindole staining (DAPI; Roche Diagnostics).
Western blot analysis
Human lung tissue specimens were homogenized in extraction
buffer [20 mM Tris-Cl, 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% (v/v) Triton X-100, supplemented with Complete
TM
Proteinase Inhibitor Cocktail (Merck Biosciences)] and whole
proteins were extracted by centrifugation (12.0006g) for 10 min
at 4uC, as described previously [43]. Samples containing 25 mgo f
protein were separated by electrophoresis on a 10% SDS-
polyacrylamide gels. The separated proteins were transferred to
nitrocellulose membranes (Invitrogen), blocked with 5% skim milk,
and incubated with the indicated antibodies. Proteins were then
visualized by enhanced chemiluminescence detection (ECL,
Amersham Biosciences, Uppsala, Sweden), as reported. Prior to
reprobing, nitrocellulose membranes were incubated with strip-
ping buffer [100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM
Tris-HCl (pH 6.7)] at 50 uC for 30 min.
Reporter gene assay
Lung epithelial A549 cells were transiently transfected with the
reporter construct TOPflash or FOPflash (kindly provided by R.
Moon, University of Washington, Seattle) using Lipofectamine
TM
2000 (Invitrogen). The TOPflash construct contains eight Tcf/Lef
binding sites upstream of a minimal TA viral promoter and the
firefly luciferase cDNA. The FOPflash construct is identical with
the exception that it contains mutated copies of TCf/Lef binding
sites and is used as a control for measuring nonspecific activation
of the reporter construct. Treatment with Wnt3a (100 ng/ml) or
Wnt7a (100 ng/ml) for 24 h was performed 4 h after transfection.
Luciferase activities were determined using the Dual Luciferase
Assay System (Promega) on a Fusion
TM luminometer (Packard
BioScience).
Collagen assay
NIH-3T3 fibroblasts were plated at a density of 30.000 cells/
well in 6-well plates, synchronized for 24 h in serum-free medium,
and treated for 24 h as indicated. Total collagen content was
determined using the Sircol Collagen Assay kit (Biocolor, Belfast,
Northern Ireland). Equal amounts of protein lysates were added to
1 ml of Sircol dye reagent, followed by 30 min of mixing. After
centrifugation at 10.0006 g for 10 min, the supernatant was
carefully aspirated and 1 ml of Alkali reagent was added. Samples
and collagen standards were then read at 540 nm on a
spectrophotometer (Bio-Rad). Collagen concentrations were
calculated using a standard curve generated by using acid-soluble
type 1 collagen.
Statistical analysis
All DCt values obtained from real-time RT-PCR were analyzed
for normal distribution using the Shapiro-Wilk test, using
assignment of a normal distribution with p.0.05. Normality of
data was confirmed using quantile-quantile plots. The means of
Table 1. Characteristics of IPF patients with UIP pattern.
No. Diagnosis Gender Age (yr) VC (%) DLCO/VA (%) TLC (%) O2 (l/min) PaO2 (mmHg) PaCO2(mmHg)
1 IPF (UIP) male 63 56% 33% 48% 3 52 33
2 IPF (UIP) male 62 50% 26% 52% 3 49 38
3 IPF (UIP) male 58 49% na na na na na
4 IPF (UIP) male 65 59% 20% 42% 3 53 38
5 IPF (UIP) male 65 59% 20% 42% 4 69 41
6 IPF (UIP) male 43 48% 27% 51% na na na
7 IPF (UIP) male 71 40% 24% 46% na na na
8 IPF (UIP) male 64 59% 22% 52% 2 58 38
9 IPF (UIP) male 60 51% 18% 49% 2 59 39
10 IPF (UIP) male 65 51% 20% 66% 2 53 38
11 IPF (UIP) male 44 47% 25% 55% 2 36 35
12 IPF (UIP) female 43 40% na na 2 54 35
13 IPF (UIP) female 42 50% 17% 58% 3 52 36
14 IPF (UIP) female 66 29% 23% 45% 4 56 45
15 IPF (UIP) female 62 27% na 48% 4 71 65
VC=vital capacity, TLC=total lung capacity, DLCO/VA=diffusing capacity of the lung for CO per unit of alveolar volume (all in % predicted), PaO2/CO2=partial pressure of
O2/CO2 in the arterial blood.
doi:10.1371/journal.pone.0002142.t001
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Gene Accession Sequences (59R39) Length Amplicon
b-Catenin NM001904 for AAGTGGGTGGTATAGAGGCTCTTG 24 bp 77 bp
rev GATGGCAGGCTCAGTGATGTC 21 bp
Cyclin D1 NM053056 for CCGAGAAGCTGTGCATCTACAC 22 bp 94 bp
rev AGGTTCCACTTGAGCTTGTTCAC 23 bp
Fn1 NM212482 for CCGACCAGAAGTTTGGGTTCT 21 bp 81 bp
rev CAATGCGGTACATGACCCCT 20 bp
Fzd1 NM003505 for AGCGCCGTGGAGTTCGT 17 bp 64 bp
rev CGAAAGAGAGTTGTCTAGTGAGGAAAC 27 bp
Fzd2 NM001466 for CACGCCGCGCATGTC 15 bp 63 bp
rev ACGATGAGCGTCATGAGGTATTT 23 bp
Fzd3 NM017412 for GGTGTTCCTTGGCCTGAAGA 20 bp 72 bp
rev CACAAGTCGAGGATATGGCTCAT 23 bp
Fzd4 NM012193 for GACAACTTTCACACCGCTCATC 22 bp 164 bp
rev CCTTCAGGACGGGTTCACA 19 bp
Hprt1 NM000194 for AAGGACCCCACGAAGTGTTG 20 bp 137 bp
rev GGCTTTGTATTTTGCTTTTCCA 22 bp
Gsk-3b NM002093 for CTCATGCTCGGATTCAAGCA 20 bp 86 bp
rev GGTCTGTCCACGGTCTCCAGTA 22 bp
Lef1 NM016269 for CATCAGGTACAGGTCCAAGAATGA 24 bp 93 bp
rev GTCGCTGCCTTGGCTTTG 18 bp
Lrp5 NM002335 for GACCCAGCCCTTTGTTTTGAC 21 bp 138 bp
rev TGTGGACGTTGATGGTATTGGT 22 bp
Lrp6 NM002336 for GATTCAGATCTCCGGCGAATT 21 bp 83 bp
rev GGCTGCAAGATATTGGAGTCTTCT 24 bp
Mmp7 NM002423 for GAACGCTGGACGGATGGTA 19 bp 64 bp
rev CAAGTTCATGAGTTGCAGCATACA 24 bp
Tcf3 NM031283 for ACCATCTCCAGCACACTTGTCTAATA 26 bp 71 bp
rev GAGTCAGCGGATGCATGTGA 20 bp
Tcf4 NM030756 for GCGCGGGATAACTATGGAAAG 21 bp 89 bp
rev GGATTTAGGAAACATTCGCTGTGT 24 bp
Wnt1 NM005430 for CTCATGAACCTTCACAACAACGA 23 bp 80 bp
rev ATCCCGTGGCACTTGCA 17 bp
Wnt2 NM003391 for CCTGATGAATCTTCACAACAACAGA 25 bp 78 bp
rev CCGTGGCACTTGCACTCTT 19 bp
Wnt3a NM033131 for GCCCCACTCGGATACTTCTTACT 23 bp 98 bp
rev GAGGAATACTGTGGCCCAACA 21 bp
Wnt7b NM058238 for GCAAGTGGATTTTCTACGTGTTTCT 25 bp 65 bp
rev TGACAGTGCTCCGAGCTTCA 20 bp
Wnt10b NM003394 for GCGCCAGGTGGTAACTGAA 19 bp 59 bp
rev TGCCTGATGTGCCATGACA 19 bp
mCyclinD1 NM007631 for ATGCCAGAGGCGGATGAGA 19 bp 98 bp
rev ATGGAGGGTGGGTTGGAAAT 20 bp
mFsp1 NM011311 for AGGAGCTACTGACCAGGGAGCT 22 bp 102 bp
rev TCATTGTCCCTGTTGCTGTCC 20 bp
mActa2 NM007392 for GCTGGTGATGATGCTCCCA 19 bp 80 bp
rev GCCCATTCCAACCATTACTCC 21 bp
mPbgd NM007392 for ATGTCCGGTAACGGCGGC 18 bp 139 bp
rev GGTACAAGGCTTTCAGCATCGC 22 bp
All primer sets worked under identical real-time PCR cycling conditions with similar efficiencies to obtain simultaneous amplification in the same run. Sequences were
taken from GeneBank, all accession numbers are denoted.
doi:10.1371/journal.pone.0002142.t002
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or a one-way analysis of variance (ANOVA) with Tukey HSD post
hoc test for studies with more than 2 groups. All p values obtained
from multiple tests were adjusted using the procedure from
Hochberg and Benjamini [45]. Results were considered statisti-
cally significant when p,0.05.
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